Emerging Biotech
Investment in Internal Process Development and Manufacturing Enables Rapid Product Development
Speed to the clinic and patient safety are important goals when working to bring novel genetic therapies to…
Alex Meola is a Scientist II in the Downstream Process Development group at Homology Medicines. He has a degree in Biochemistry & Biophysics from Rensselaer Polytechnic Institute and has experience working in downstream process development, formulation development, and manufacturing. His experience includes developing processes to purify complex drug modalities including AAVs, nanoparticles, liposomes, and recombinant proteins.
Speed to the clinic and patient safety are important goals when working to bring novel genetic therapies to…